| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.849 | 0.003 | 0.849 | Vasodilator, coronary | 0.752 0.004 DBMET01140 | ||
| 0.696 | 0.006 | 0.744 | Vasodilator, peripheral | 0.744 0.005 DBMET01140 | DBMET01140 | |
| 0.61 | 0.012 | 0.61 | Spasmolytic | 0.462 0.029 DBMET01140 | ||
| 0.585 | 0.005 | 0.585 | Diuretic | 0.541 0.006 DBMET01140 | ||
| 0.565 | 0.02 | 0.565 | Antithrombotic | 0.544 0.023 DBMET01140 | ||
| 0.47 | 0.014 | 0.47 | Vasodilator | 0.449 0.016 DBMET01140 | ||
| 0.399 | 0.003 | 0.451 | Angiotensin-converting enzyme inhibitor | 0.451 0.002 DBMET01140 | DBMET01140 | |
| 0.447 | 0.053 | 0.447 | 5 Hydroxytryptamine release inhibitor | 0.315 0.149 DBMET01140 | ||
| 0.375 | 0.005 | 0.396 | Neurotrophic factor | 0.396 0.005 DBMET01140 | DBMET01140 | |
| 0.373 | 0.014 | 0.415 | Thrombolytic | 0.415 0.01 DBMET01140 | DBMET01140 | |
| 0.382 | 0.032 | 0.382 | Cardiotonic | 0.365 0.035 DBMET01140 | ||
| 0.41 | 0.07 | 0.41 | Histamine release inhibitor | 0.317 0.115 DBMET01140 | ||
| 0.391 | 0.052 | 0.391 | Immunostimulant | 0.381 0.055 DBMET01140 | ||
| 0.363 | 0.029 | 0.383 | Psychostimulant | 0.383 0.025 DBMET01140 | DBMET01140 | |
| 0.333 | 0.016 | 0.333 | Thiol protease inhibitor | 0.299 0.019 DBMET01140 | ||
| 0.342 | 0.04 | 0.374 | Platelet antagonist | 0.374 0.033 DBMET01140 | DBMET01140 | |
| 0.329 | 0.043 | 0.329 | Insulysin inhibitor | 0.328 0.043 DBMET01140 | ||
| 0.292 | 0.018 | 0.3 | Insulin sensitizer | 0.3 0.016 DBMET01140 | DBMET01140 | |
| 0.287 | 0.016 | 0.313 | Neurotensin receptor agonist | 0.313 0.013 DBMET01140 | DBMET01140 | |
| 0.308 | 0.044 | 0.338 | Interleukin agonist | 0.338 0.033 DBMET01140 | DBMET01140 | |
| 0.343 | 0.079 | 0.343 | Transcription factor NF kappa B inhibitor | 0.301 0.094 DBMET01140 | ||
| 0.285 | 0.031 | 0.314 | Anticoagulant | 0.314 0.026 DBMET01140 | DBMET01140 | |
| 0.274 | 0.035 | 0.274 | P-glycoprotein inhibitor | 0.251 0.041 DBMET01140 | ||
| 0.29 | 0.053 | 0.309 | Angiogenesis stimulant | 0.309 0.046 DBMET01140 | DBMET01140 | |
| 0.284 | 0.058 | 0.284 | Hypoglycemic | 0.257 0.073 DBMET01140 | ||
| 0.295 | 0.071 | 0.295 | 5 Hydroxytryptamine release stimulant | 0.203 0.119 DBMET01140 | ||
| 0.332 | 0.131 | 0.332 | Calcium channel L-type activator | 0.266 0.188 DBMET01140 | ||
| 0.216 | 0.018 | 0.249 | Aminopeptidase B inhibitor | 0.249 0.013 DBMET01140 | DBMET01140 | |
| 0.279 | 0.09 | 0.341 | Interleukin 2 agonist | 0.341 0.05 DBMET01140 | DBMET01140 | |
| 0.28 | 0.104 | 0.28 | Cholesterol antagonist | 0.203 0.162 DBMET01140 | ||
| 0.196 | 0.026 | 0.235 | Cell adhesion inhibitor | 0.235 0.017 DBMET01140 | DBMET01140 | |
| 0.243 | 0.075 | 0.261 | Tyrosine 3 hydroxylase inhibitor | 0.261 0.059 DBMET01140 | DBMET01140 | |
| 0.24 | 0.081 | 0.377 | Superoxide dismutase inhibitor | 0.377 0.031 DBMET01140 | DBMET01140 | |
| 0.308 | 0.155 | 0.33 | Cyclophilin D inhibitor | 0.33 0.138 DBMET01140 | DBMET01140 | |
| 0.21 | 0.066 | 0.227 | Platelet adhesion inhibitor | 0.227 0.058 DBMET01140 | DBMET01140 | |
| 0.26 | 0.118 | 0.307 | Sodium/bile acid cotransporter inhibitor | 0.307 0.073 DBMET01140 | DBMET01140 | |
| 0.306 | 0.168 | 0.306 | Apoptosis agonist | 0.29 0.179 DBMET01140 | ||
| 0.271 | 0.134 | 0.271 | Immunosuppressant | 0.264 0.138 DBMET01140 | ||
| 0.138 | 0.004 | 0.144 | Prolyl endopeptidase inhibitor | 0.144 0.003 DBMET01140 | DBMET01140 | |
| 0.171 | 0.055 | 0.184 | Protein kinase stimulant | 0.184 0.048 DBMET01140 | DBMET01140 | |
| 0.157 | 0.043 | 0.157 | Proteasome inhibitor | 0.134 0.055 DBMET01140 | ||
| 0.136 | 0.028 | 0.175 | Folate antagonist | 0.175 0.015 DBMET01140 | DBMET01140 | |
| 0.127 | 0.021 | 0.154 | Cell adhesion molecule inhibitor | 0.154 0.014 DBMET01140 | DBMET01140 | |
| 0.112 | 0.009 | 0.112 | Leukocyte elastase inhibitor | 0.072 0.014 DBMET01140 | ||
| 0.141 | 0.039 | 0.141 | Expectorant | 0.132 0.044 DBMET01140 | ||
| 0.204 | 0.105 | 0.204 | Tumour necrosis factor alpha release inhibitor | 0.19 0.118 DBMET01140 | ||
| 0.12 | 0.026 | 0.155 | Opioid delta receptor antagonist | 0.155 0.019 DBMET01140 | DBMET01140 | |
| 0.129 | 0.035 | 0.129 | Acetylcholine release stimulant | |||
| 0.095 | 0.003 | 0.151 | Angiotensin-converting enzyme 2 inhibitor | 0.151 0.003 DBMET01140 | DBMET01140 | |
| 0.133 | 0.043 | 0.133 | Mucolytic | 0.124 0.05 DBMET01140 | ||
| 0.174 | 0.085 | 0.174 | Hepatoprotectant | 0.167 0.092 DBMET01140 | ||
| 0.105 | 0.017 | 0.105 | Elastase 1 inhibitor | 0.091 0.026 DBMET01140 | ||
| 0.232 | 0.145 | 0.242 | Apoptosis antagonist | 0.242 0.135 DBMET01140 | DBMET01140 | |
| 0.138 | 0.052 | 0.138 | Vanilloid 1 agonist | 0.127 0.073 DBMET01140 | ||
| 0.191 | 0.105 | 0.191 | Free radical scavenger | 0.191 0.105 DBMET01140 | ||
| 0.12 | 0.036 | 0.15 | Opioid antagonist | 0.15 0.026 DBMET01140 | DBMET01140 | |
| 0.1 | 0.021 | 0.12 | Glucagon-like peptide 1 agonist | 0.12 0.014 DBMET01140 | DBMET01140 | |
| 0.12 | 0.044 | 0.129 | Falcipain inhibitor | 0.129 0.04 DBMET01140 | DBMET01140 | |
| 0.157 | 0.082 | 0.221 | Growth hormone agonist | 0.221 0.051 DBMET01140 | DBMET01140 | |
| 0.161 | 0.087 | 0.161 | Tumour necrosis factor antagonist | 0.141 0.113 DBMET01140 | ||
| 0.14 | 0.067 | 0.148 | Bone formation stimulant | 0.148 0.06 DBMET01140 | DBMET01140 | |
| 0.093 | 0.02 | 0.093 | Beta adrenoreceptor antagonist | 0.071 0.037 DBMET01140 | ||
| 0.116 | 0.044 | 0.125 | Falcipain 2 inhibitor | 0.125 0.04 DBMET01140 | DBMET01140 | |
| 0.217 | 0.146 | 0.225 | Caspase 3 stimulant | 0.225 0.137 DBMET01140 | DBMET01140 | |
| 0.174 | 0.103 | 0.174 | Platelet aggregation inhibitor | 0.173 0.103 DBMET01140 | ||
| 0.143 | 0.076 | 0.16 | Hemostatic | 0.16 0.057 DBMET01140 | DBMET01140 | |
| 0.08 | 0.016 | 0.102 | Metalloproteinase-3 inhibitor | 0.102 0.01 DBMET01140 | DBMET01140 | |
| 0.097 | 0.033 | 0.109 | Analgesic, opioid | 0.109 0.027 DBMET01140 | DBMET01140 | |
| 0.097 | 0.033 | 0.124 | Opioid mu receptor antagonist | 0.124 0.024 DBMET01140 | DBMET01140 | |
| 0.093 | 0.03 | 0.125 | Matrix metalloproteinase inhibitor | 0.125 0.018 DBMET01140 | DBMET01140 | |
| 0.113 | 0.053 | 0.113 | Protease inhibitor | 0.11 0.057 DBMET01140 | ||
| 0.099 | 0.039 | 0.153 | Metalloproteinase-2 inhibitor | 0.153 0.018 DBMET01140 | DBMET01140 | |
| 0.077 | 0.021 | 0.107 | Matrix metalloproteinase (membrane-type) inhibitor | 0.107 0.013 DBMET01140 | DBMET01140 | |
| 0.183 | 0.13 | 0.183 | Calpain inhibitor | |||
| 0.172 | 0.121 | 0.232 | Antiamyloidogenic | 0.232 0.08 DBMET01140 | DBMET01140 | |
| 0.092 | 0.042 | 0.092 | Chymotrypsin inhibitor | 0.087 0.046 DBMET01140 | ||
| 0.093 | 0.045 | 0.106 | Factor XII inhibitor | 0.106 0.032 DBMET01140 | DBMET01140 | |
| 0.072 | 0.028 | 0.077 | Cathepsin E inhibitor | 0.077 0.024 DBMET01140 | DBMET01140 | |
| 0.12 | 0.075 | 0.179 | Cathepsin H inhibitor | 0.179 0.03 DBMET01140 | DBMET01140 | |
| 0.072 | 0.03 | 0.072 | Nitric oxide donor | 0.057 0.054 DBMET01140 | ||
| 0.049 | 0.009 | 0.062 | Glutamate (mGluR8) antagonist | 0.062 0.005 DBMET01140 | DBMET01140 | |
| 0.132 | 0.094 | 0.147 | Insulin secretagoues | 0.147 0.078 DBMET01140 | DBMET01140 | |
| 0.046 | 0.01 | 0.06 | Angiotensin AT2 receptor antagonist | 0.06 0.008 DBMET01140 | DBMET01140 | |
| 0.063 | 0.027 | 0.063 | Elastase inhibitor | 0.059 0.031 DBMET01140 | ||
| 0.041 | 0.009 | 0.058 | Neutral endopeptidase inhibitor | 0.058 0.006 DBMET01140 | DBMET01140 | |
| 0.056 | 0.025 | 0.08 | HCV NS3/NS4A protease inhibitor | 0.08 0.011 DBMET01140 | DBMET01140 | |
| 0.077 | 0.045 | 0.079 | Thrombin inhibitor | 0.079 0.043 DBMET01140 | DBMET01140 | |
| 0.05 | 0.02 | 0.053 | Baculoviral IAP repeat-containing protein inhibitor | 0.053 0.014 DBMET01140 | DBMET01140 | |
| 0.047 | 0.018 | 0.051 | Phenylethanolamine N methyltransferase inhibitor | 0.051 0.013 DBMET01140 | DBMET01140 | |
| 0.066 | 0.042 | 0.066 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.063 | 0.042 | 0.066 | Trypsin inhibitor | 0.066 0.037 DBMET01140 | DBMET01140 | |
| 0.079 | 0.059 | 0.093 | Opioid kappa receptor antagonist | 0.093 0.043 DBMET01140 | DBMET01140 | |
| 0.049 | 0.029 | 0.075 | Neurotensin receptor antagonist | 0.075 0.019 DBMET01140 | DBMET01140 | |
| 0.056 | 0.038 | 0.056 | Human rhinovirus A protease inhibitor | 0.05 0.043 DBMET01140 | ||
| 0.071 | 0.053 | 0.078 | Cathepsin G inhibitor | 0.078 0.045 DBMET01140 | DBMET01140 | |
| 0.096 | 0.079 | 0.098 | Factor V inhibitor | 0.098 0.074 DBMET01140 | DBMET01140 | |
| 0.125 | 0.111 | 0.125 | Neuropeptide Y1 antagonist | |||
| 0.046 | 0.032 | 0.054 | Opioid mu receptor agonist | 0.054 0.026 DBMET01140 | DBMET01140 | |
| 0.056 | 0.043 | 0.066 | Aminopeptidase microsomal inhibitor | 0.066 0.034 DBMET01140 | DBMET01140 | |
| 0.033 | 0.021 | 0.044 | Caspase 2 inhibitor | 0.044 0.014 DBMET01140 | DBMET01140 | |
| 0.038 | 0.026 | 0.043 | Leukotriene A4 hydrolase inhibitor | 0.043 0.023 DBMET01140 | DBMET01140 | |
| 0.189 | 0.178 | 0.198 | Immunomodulator | 0.198 0.166 DBMET01140 | DBMET01140 | |
| 0.067 | 0.057 | 0.115 | Aminopeptidase I inhibitor | 0.115 0.021 DBMET01140 | DBMET01140 | |
| 0.123 | 0.113 | 0.123 | Phospholipase A2 inhibitor | |||
| 0.183 | 0.174 | 0.243 | Gastrin inhibitor | 0.243 0.087 DBMET01140 | DBMET01140 | |
| 0.034 | 0.025 | 0.037 | Angiotensin II receptor antagonist | 0.037 0.018 DBMET01140 | DBMET01140 | |
| 0.081 | 0.072 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.09 | 0.081 | 0.137 | Falcipain 3 inhibitor | 0.137 0.043 DBMET01140 | DBMET01140 | |
| 0.057 | 0.049 | 0.058 | Bcl-xL inhibitor | 0.058 0.047 DBMET01140 | DBMET01140 | |
| 0.058 | 0.051 | 0.061 | Caspase 9 inhibitor | 0.061 0.045 DBMET01140 | DBMET01140 | |
| 0.035 | 0.028 | 0.035 | Integrin alpha2 antagonist | 0.035 0.03 DBMET01140 | ||
| 0.16 | 0.154 | 0.16 | Antioxidant | |||
| 0.085 | 0.08 | 0.095 | Interleukin 1 beta converting enzyme inhibitor | 0.095 0.064 DBMET01140 | DBMET01140 | |
| 0.043 | 0.039 | 0.058 | GP IIb/IIIa receptor antagonist | 0.058 0.029 DBMET01140 | DBMET01140 | |
| 0.079 | 0.075 | 0.087 | Hematopoietic | 0.087 0.055 DBMET01140 | DBMET01140 | |
| 0.078 | 0.075 | 0.078 | Vanilloid agonist | |||
| 0.046 | 0.045 | 0.055 | Opioid agonist | 0.055 0.034 DBMET01140 | DBMET01140 | |
| 0.019 | 0.019 | 0.02 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.02 0.017 DBMET01140 | DBMET01140 | |
| 0.012 | 0.014 | 0.027 | Integrin alpha4beta1 antagonist | 0.027 0.008 DBMET01140 | DBMET01140 | |
| 0.042 | 0.044 | 0.074 | Matrix metalloproteinase 1 inhibitor | 0.074 0.024 DBMET01140 | DBMET01140 | |
| 0.01 | 0.014 | 0.02 | Glucagon agonist | 0.02 0.008 DBMET01140 | DBMET01140 | |
| 0.038 | 0.042 | 0.04 | Plasmin inhibitor | 0.04 0.039 DBMET01140 | DBMET01140 | |
| 0.028 | 0.033 | 0.051 | Arginase inhibitor | 0.051 0.014 DBMET01140 | DBMET01140 | |
| 0.03 | 0.035 | 0.033 | Opioid delta receptor agonist | 0.033 0.028 DBMET01140 | DBMET01140 | |
| 0.027 | 0.032 | 0.032 | Calcitonin receptor agonist | 0.032 0.025 DBMET01140 | DBMET01140 | |
| 0.054 | 0.059 | 0.093 | Neutrophil collagenase inhibitor | 0.093 0.025 DBMET01140 | DBMET01140 | |
| 0.115 | 0.12 | 0.134 | Protein-tyrosine phosphatase inhibitor | 0.134 0.096 DBMET01140 | DBMET01140 | |
| 0.038 | 0.044 | 0.046 | Aminopeptidase N inhibitor | 0.046 0.035 DBMET01140 | DBMET01140 | |
| 0.043 | 0.05 | 0.05 | Collagenase inhibitor | 0.05 0.032 DBMET01140 | DBMET01140 | |
| 0.022 | 0.03 | 0.026 | NMDA 2D receptor antagonist | 0.026 0.02 DBMET01140 | DBMET01140 | |
| 0.034 | 0.043 | 0.04 | Integrin alpha1beta1 antagonist | 0.04 0.021 DBMET01140 | DBMET01140 | |
| 0.033 | 0.042 | 0.038 | Melanocortin 4 antagonist | 0.038 0.034 DBMET01140 | DBMET01140 | |
| 0.029 | 0.043 | 0.034 | Cholecystokinin B agonist | 0.034 0.031 DBMET01140 | DBMET01140 | |
| 0.014 | 0.029 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.013 DBMET01140 | DBMET01140 | |
| 0.063 | 0.078 | 0.07 | Somatostatin 1 agonist | 0.07 0.064 DBMET01140 | DBMET01140 | |
| 0.044 | 0.06 | 0.058 | Dipeptidyl peptidase inhibitor | 0.058 0.029 DBMET01140 | DBMET01140 | |
| 0.026 | 0.042 | 0.085 | Integrin antagonist | 0.085 0.019 DBMET01140 | DBMET01140 | |
| 0.04 | 0.059 | 0.051 | Plasminogen activator inhibitor | 0.051 0.047 DBMET01140 | DBMET01140 | |
| 0.056 | 0.075 | 0.062 | Prolactin release inhibitor | 0.062 0.042 DBMET01140 | DBMET01140 | |
| 0.014 | 0.034 | 0.037 | Integrin alpha4 antagonist | 0.037 0.014 DBMET01140 | DBMET01140 | |
| 0.041 | 0.063 | 0.054 | CD45 antagonist | 0.054 0.028 DBMET01140 | DBMET01140 | |
| 0.08 | 0.103 | 0.094 | Protein-tyrosine phosphatase 1B inhibitor | 0.094 0.085 DBMET01140 | DBMET01140 | |
| 0.037 | 0.061 | 0.045 | Dipeptidyl peptidase IV inhibitor | 0.045 0.029 DBMET01140 | DBMET01140 | |
| 0.019 | 0.045 | 0.033 | LFA antagonist | 0.033 0.013 DBMET01140 | DBMET01140 | |
| 0.027 | 0.054 | 0.04 | Endothelin-converting enzyme inhibitor | 0.04 0.039 DBMET01140 | DBMET01140 | |
| 0.016 | 0.044 | 0.032 | Lysine carboxypeptidase inhibitor | 0.032 0.014 DBMET01140 | DBMET01140 | |
| 0.027 | 0.056 | 0.032 | HCV polyprotein inhibitor | 0.032 0.03 DBMET01140 | DBMET01140 | |
| 0.028 | 0.059 | 0.039 | Integrin alpha5beta1 antagonist | 0.039 0.031 DBMET01140 | DBMET01140 | |
| 0.057 | 0.091 | 0.085 | Metalloproteinase-9 inhibitor | 0.085 0.041 DBMET01140 | DBMET01140 | |
| 0.005 | 0.039 | 0.011 | Integrin beta2 antagonist | 0.011 0.01 DBMET01140 | DBMET01140 | |
| 0.02 | 0.055 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.02 DBMET01140 | DBMET01140 | |
| 0.021 | 0.059 | 0.058 | Kainate receptor antagonist | 0.058 0.017 DBMET01140 | DBMET01140 | |
| 0.02 | 0.058 | 0.044 | Complement C3a chemotactic receptor antagonist | 0.044 0.03 DBMET01140 | DBMET01140 | |
| 0.037 | 0.085 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.043 DBMET01140 | DBMET01140 | |
| 0.012 | 0.061 | 0.027 | AMPA 2 receptor antagonist | 0.027 0.023 DBMET01140 | DBMET01140 | |
| 0.007 | 0.062 | 0.025 | VLA-4 antagonist | 0.025 0.019 DBMET01140 | DBMET01140 | |
| 0.022 | 0.081 | 0.057 | NMDA 2A receptor antagonist | 0.057 0.032 DBMET01140 | DBMET01140 | |
| 0.087 | 0.147 | 0.112 | Histone deacetylase SIRT1 inhibitor | 0.112 0.101 DBMET01140 | DBMET01140 | |
| 0.106 | 0.169 | 0.157 | DNA methyltransferase I inhibitor | 0.157 0.097 DBMET01140 | DBMET01140 | |
| 0.05 | 0.126 | 0.075 | NMDA receptor antagonist | 0.075 0.072 DBMET01140 | DBMET01140 | |
| 0.07 | 0.159 | 0.11 | Glutamate (mGluR7) agonist | 0.11 0.042 DBMET01140 | DBMET01140 | |
| 0.018 | 0.11 | 0.043 | Glycine transporter 2 inhibitor | 0.043 0.036 DBMET01140 | DBMET01140 | |
| 0.101 | 0.193 | 0.127 | Interferon gamma antagonist | 0.127 0.117 DBMET01140 | DBMET01140 | |
| 0.1 | 0.194 | 0.168 | DNA methylase inhibitor | 0.168 0.102 DBMET01140 | DBMET01140 | |
| 0.155 | 0.273 | 0.226 | 5 Hydroxytryptamine uptake stimulant | 0.226 0.109 DBMET01140 | DBMET01140 | |
| 0.048 | 0.206 | 0.099 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET01140 | DBMET01140 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |